MA23942A1 - Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation - Google Patents

Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation

Info

Publication number: MA23942A1
Authority: MA; Morocco
Prior art keywords: preparation; formulation containing; novel formulation; containing paroxetine; paroxetine
Prior art date: 1995-07-20

Application number

MA24317A

Other languages

English (en)

Inventor

Philip Elder David

Stanley Leonard Graham

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-20

Filing date

1996-07-18

Publication date

1997-04-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10777960&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA23942(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-07-18 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1997-04-01 Publication of MA23942A1 publication Critical patent/MA23942A1/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polyurethanes Or Polyureas (AREA)
Hydrogenated Pyridines (AREA)

MA24317A 1995-07-20 1996-07-18 Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation MA23942A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9514842.5A GB9514842D0 (en)	1995-07-20	1995-07-20	Novel formulation

Publications (1)

Publication Number	Publication Date
MA23942A1 true MA23942A1 (fr)	1997-04-01

Family

ID=10777960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24317A MA23942A1 (fr)	1995-07-20	1996-07-18	Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation

Country Status (41)

Country	Link
EP (2)	EP1382337A1 (fr)
JP (2)	JP3922392B2 (fr)
KR (1)	KR100468351B1 (fr)
CN (2)	CN1117567C (fr)
AP (1)	AP1052A (fr)
AR (1)	AR003463A1 (fr)
AT (1)	ATE253361T1 (fr)
AU (1)	AU6659196A (fr)
BG (1)	BG64076B1 (fr)
BR (1)	BR9609857A (fr)
CA (2)	CA2445678C (fr)
CY (1)	CY2408B1 (fr)
CZ (1)	CZ294110B6 (fr)
DE (1)	DE69630603T3 (fr)
DK (1)	DK0839039T4 (fr)
DZ (1)	DZ2074A1 (fr)
EA (2)	EA003508B1 (fr)
EG (1)	EG23934A (fr)
ES (1)	ES2208757T5 (fr)
GB (1)	GB9514842D0 (fr)
HK (1)	HK1010494A1 (fr)
HU (1)	HU228853B1 (fr)
IL (1)	IL122940A0 (fr)
MA (1)	MA23942A1 (fr)
MX (1)	MX9800571A (fr)
MY (1)	MY141373A (fr)
NO (1)	NO315637B1 (fr)
NZ (1)	NZ315006A (fr)
OA (1)	OA10652A (fr)
PE (1)	PE16098A1 (fr)
PL (1)	PL184987B1 (fr)
PT (1)	PT839039E (fr)
RO (1)	RO119119B1 (fr)
SI (1)	SI0839039T2 (fr)
SK (1)	SK284117B6 (fr)
TR (1)	TR199800077T1 (fr)
TW (1)	TW464513B (fr)
UA (1)	UA68328C2 (fr)
UY (3)	UY24288A1 (fr)
WO (1)	WO1997003670A1 (fr)
ZA (1)	ZA966148B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6638948B1 (en)	1996-09-09	2003-10-28	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
US5910319A (en) *	1997-05-29	1999-06-08	Eli Lilly And Company	Fluoxetine enteric pellets and methods for their preparation and use
ES2155995T3 (es)	1997-06-10	2001-06-01	Synthon Bv	Compuestos de 4-fenilpiperidina.
US5955475A (en) *	1997-06-30	1999-09-21	Endo Pharmaceuticals Inc.	Process for manufacturing paroxetine solid dispersions
AU739261B2 (en)	1997-07-01	2001-10-11	Pfizer Inc.	Sertraline salts and sustained-release dosage forms of sertraline
GB9808479D0 (en) *	1998-04-22	1998-06-17	Smithkline Beecham Plc	Method of treatment
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US6139875A (en) *	1998-09-29	2000-10-31	Eastman Chemical Company	Aqueous enteric coating composition and low gastric permeability enteric coating
ATE311883T1 (de)	1999-03-12	2005-12-15	Aesica Pharmaceuticals Ltd	Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
RU2275191C2 (ru) *	1999-05-20	2006-04-27	Элан Корпорейшн, Плс	Состоящие из множества частиц фармацевтические составы с контролируемым высвобождением избирательного ингибитора повторного поглощения серотонина
IE990406A1 (en)	1999-05-20	2000-12-27	Elan Corp Plc	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
ES2159260B1 (es) *	1999-06-22	2002-05-01	Smithkline Beechan Plc	Nueva composicion de metanosulfonato de paroxetina
AU5078700A (en) *	1999-06-22	2001-01-09	Smithkline Beecham Plc	Novel composition
ES2162560B1 (es) *	1999-06-25	2002-07-16	Rodriguez Concepcion Pena	Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
AR030557A1 (es) *	2000-04-14	2003-08-27	Jagotec Ag	Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6482440B2 (en) *	2000-09-21	2002-11-19	Phase 2 Discovery, Inc.	Long acting antidepressant microparticles
CA2457385A1 (fr) *	2001-08-06	2003-02-20	Dr. Reddy's Laboratories Ltd.	Preparation enterique de fluoxetine
GB2392385A (en) *	2002-09-02	2004-03-03	Cipla Ltd	Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone
TW200517106A (en)	2003-10-29	2005-06-01	Wyeth Corp	Sustained release pharmaceutical compositions
EP1734920A2 (fr) *	2004-02-13	2006-12-27	Neuromolecular Inc.	Combinaison d'un antagoniste du recepteur nmda et d'un inhibiteur mao ou gadpf pour le traitement des troubles psychiatriques
WO2005107716A1 (fr) *	2004-03-25	2005-11-17	Cadila Healthcare Limited	Comprimes a liberation lente a base de paroxetine comprenant un noyau et un revetement
JP5153629B2 (ja) *	2005-08-02	2013-02-27	ルピン・リミテッド	選択的セロトニン再取り込み阻害剤の新規の制御放出組成物
KR100591142B1 (ko) *	2005-11-04	2006-06-20	지엘팜텍 주식회사	파록세틴을 활성물질로 함유하는 장용성 서방형 정제
US20090130206A1 (en) *	2006-05-09	2009-05-21	Umesh Nandkumar Khatavkar	Controlled Release Compositions of an Antidepressant Agent
KR100885029B1 (ko)	2007-02-07	2009-02-23	지엘팜텍 주식회사	경구투여용 서방성 삼중정제
WO2009006299A2 (fr) *	2007-06-29	2009-01-08	Dr. Reddy's Laboratories Ltd.	Systèmes à multiples particules
CA2698808A1 (fr)	2007-09-13	2009-03-19	Concert Pharmaceuticals, Inc.	Synthese de benzo[d][1,3]dioxoles et de catechols deuteries, ainsi que de leurs derives
TW201010743A (en)	2008-09-05	2010-03-16	Otsuka Pharma Co Ltd	Pharmaceutical solid preparation
DK2470166T3 (da) *	2009-08-24	2013-09-08	Lundbeck & Co As H	Nye sammensætninger af 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazin
CN103371982A (zh) *	2012-04-20	2013-10-30	王进京	盐酸帕罗西汀肠溶控释片新型处方组成及制备方法
JP2015522047A (ja) *	2012-07-09	2015-08-03	ユニリーバー・ナームローゼ・ベンノートシヤープ	光保護パーソナルケア組成物
CN103550182B (zh) *	2013-10-29	2015-04-08	吉林省东盟制药有限公司	一种肠溶缓释组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8626936D0 (en) *	1986-11-11	1986-12-10	Ferrosan As	Treatment
MC2025A1 (fr) *	1988-04-20	1990-04-25	Asta Pharma Ag	Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IT1237904B (it) *	1989-12-14	1993-06-18	Ubaldo Conte	Compresse a rilascio a velocita' controllata delle sostanze attive
JPH0436237A (ja) *	1990-06-01	1992-02-06	Taiho Yakuhin Kogyo Kk	抗腫瘍性複合製剤
DK0497956T3 (da) *	1990-08-21	1996-08-12	Theratech Inc	Præparater med reguleret frigivelse
EP0558679A1 (fr) *	1990-11-24	1993-09-08	BEECHAM GROUP plc	Utilisation de paroxetine pour le traitement de la demence senile, la boulimie, la migraine ou l'anorexie
HUT69390A (en) *	1991-05-07	1995-09-28	Dynagen Inc	Controlled, sustained release delivery system for smoking cessation
JPH05139964A (ja) *	1991-11-14	1993-06-08	Takada Seiyaku Kk	塩酸メキシレチン腸溶性製剤
ES2168290T3 (es) *	1993-11-23	2002-06-16	Euro Celtique Sa	Metodo para preparar una composicion de liberacion sostenida.
IT1274241B (it) *	1993-12-03	1997-07-15	Smithkline Beecham Farma	Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
CA2143070C (fr) *	1994-02-22	2001-12-18	Pankaj Modi	Formulation pharmaceutique sous forme de suspension liquide administree par voie orale, pour degagement prolonge
GB9422154D0 (en) *	1994-11-03	1994-12-21	Euro Celtique Sa	Pharmaceutical compositions and method of producing the same
MX9707585A (es) *	1995-04-03	1997-12-31	Abbott Lab	Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.

1995
- 1995-07-20 GB GBGB9514842.5A patent/GB9514842D0/en active Pending
1996
- 1996-07-17 DZ DZ960118A patent/DZ2074A1/fr active
- 1996-07-18 MY MYPI96002956A patent/MY141373A/en unknown
- 1996-07-18 AR ARP960103639A patent/AR003463A1/es not_active Application Discontinuation
- 1996-07-18 MA MA24317A patent/MA23942A1/fr unknown
- 1996-07-18 EG EG68296A patent/EG23934A/xx active
- 1996-07-19 EA EA200100022A patent/EA003508B1/ru not_active IP Right Cessation
- 1996-07-19 EP EP03078259A patent/EP1382337A1/fr not_active Withdrawn
- 1996-07-19 MX MX9800571A patent/MX9800571A/es active IP Right Grant
- 1996-07-19 UA UA98010283A patent/UA68328C2/uk unknown
- 1996-07-19 CN CN96196819A patent/CN1117567C/zh not_active Expired - Lifetime
- 1996-07-19 ES ES96926388T patent/ES2208757T5/es not_active Expired - Lifetime
- 1996-07-19 DE DE69630603T patent/DE69630603T3/de not_active Expired - Lifetime
- 1996-07-19 WO PCT/EP1996/003252 patent/WO1997003670A1/fr active IP Right Grant
- 1996-07-19 EA EA199800140A patent/EA003775B1/ru not_active IP Right Cessation
- 1996-07-19 RO RO98-00082A patent/RO119119B1/ro unknown
- 1996-07-19 SK SK53-98A patent/SK284117B6/sk not_active IP Right Cessation
- 1996-07-19 HU HU9900299A patent/HU228853B1/hu unknown
- 1996-07-19 AU AU66591/96A patent/AU6659196A/en not_active Abandoned
- 1996-07-19 EP EP96926388A patent/EP0839039B2/fr not_active Expired - Lifetime
- 1996-07-19 PE PE1996000548A patent/PE16098A1/es not_active IP Right Cessation
- 1996-07-19 IL IL12294096A patent/IL122940A0/xx not_active IP Right Cessation
- 1996-07-19 AT AT96926388T patent/ATE253361T1/de active
- 1996-07-19 CZ CZ1998183A patent/CZ294110B6/cs not_active IP Right Cessation
- 1996-07-19 JP JP50632597A patent/JP3922392B2/ja not_active Expired - Lifetime
- 1996-07-19 BR BR9609857A patent/BR9609857A/pt not_active Application Discontinuation
- 1996-07-19 DK DK96926388T patent/DK0839039T4/da active
- 1996-07-19 PL PL96324553A patent/PL184987B1/pl unknown
- 1996-07-19 KR KR10-1998-0700380A patent/KR100468351B1/ko not_active IP Right Cessation
- 1996-07-19 ZA ZA9606148A patent/ZA966148B/xx unknown
- 1996-07-19 AP APAP/P/1998/001177A patent/AP1052A/en active
- 1996-07-19 TR TR1998/00077T patent/TR199800077T1/xx unknown
- 1996-07-19 CA CA002445678A patent/CA2445678C/fr not_active Expired - Lifetime
- 1996-07-19 CN CNB031490468A patent/CN1282456C/zh not_active Expired - Lifetime
- 1996-07-19 NZ NZ315006A patent/NZ315006A/xx not_active IP Right Cessation
- 1996-07-19 TW TW085108758A patent/TW464513B/zh not_active IP Right Cessation
- 1996-07-19 SI SI9630661T patent/SI0839039T2/sl unknown
- 1996-07-19 UY UY24288A patent/UY24288A1/es not_active IP Right Cessation
- 1996-07-19 PT PT96926388T patent/PT839039E/pt unknown
- 1996-07-19 CA CA002227298A patent/CA2227298C/fr not_active Expired - Lifetime
1997
- 1997-01-10 UY UY24436A patent/UY24436A1/es not_active IP Right Cessation
1998
- 1998-01-19 NO NO19980240A patent/NO315637B1/no not_active IP Right Cessation
- 1998-01-20 OA OA9800005A patent/OA10652A/en unknown
- 1998-02-17 BG BG102259A patent/BG64076B1/bg unknown
- 1998-11-06 HK HK98111807A patent/HK1010494A1/xx not_active IP Right Cessation
2000
- 2000-07-13 UY UY26242A patent/UY26242A1/es not_active Application Discontinuation
2004
- 2004-03-15 CY CY0400019A patent/CY2408B1/xx unknown
2006
- 2006-04-27 JP JP2006123731A patent/JP2006265258A/ja active Pending

Also Published As

Publication number	Publication date
UY26242A1 (es)	2001-01-31
AP9801177A0 (en)	1998-01-31
SI0839039T1 (en)	2004-04-30
UA68328C2 (en)	2004-08-16
JP3922392B2 (ja)	2007-05-30
JP2006265258A (ja)	2006-10-05
BG102259A (en)	1998-09-30
DE69630603T3 (de)	2008-01-03
AR003463A1 (es)	1998-08-05
ATE253361T1 (de)	2003-11-15
KR19990029076A (ko)	1999-04-15
CA2445678A1 (fr)	1997-02-06
EA200100022A1 (ru)	2001-06-25
AP1052A (en)	2002-03-21
EP1382337A1 (fr)	2004-01-21
SI0839039T2 (sl)	2007-10-31
UY24288A1 (es)	1997-01-16
OA10652A (en)	2002-09-18
EA003508B1 (ru)	2003-06-26
EP0839039B1 (fr)	2003-11-05
CA2227298A1 (fr)	1997-02-06
IL122940A0 (en)	1998-08-16
CA2227298C (fr)	2003-12-09
EP0839039B2 (fr)	2007-06-06
SK284117B6 (sk)	2004-09-08
PL324553A1 (en)	1998-06-08
PL184987B1 (pl)	2003-01-31
WO1997003670A1 (fr)	1997-02-06
DE69630603T2 (de)	2004-09-23
JPH11509539A (ja)	1999-08-24
BG64076B1 (bg)	2003-12-31
CZ294110B6 (cs)	2004-10-13
KR100468351B1 (ko)	2005-03-16
MX9800571A (es)	1998-04-30
HUP9900299A2 (hu)	1999-09-28
CN1282456C (zh)	2006-11-01
UY24436A1 (es)	2001-08-27
DZ2074A1 (fr)	2002-07-22
HK1010494A1 (en)	1999-06-25
MY141373A (en)	2010-04-16
CN1515257A (zh)	2004-07-28
TW464513B (en)	2001-11-21
NO315637B1 (no)	2003-10-06
ES2208757T3 (es)	2004-06-16
BR9609857A (pt)	1999-03-16
EA199800140A1 (ru)	1998-10-29
NZ315006A (en)	2000-01-28
TR199800077T1 (xx)	1998-05-21
HUP9900299A3 (en)	1999-11-29
AU6659196A (en)	1997-02-18
DE69630603D1 (de)	2003-12-11
EA003775B1 (ru)	2003-08-28
ZA966148B (en)	1998-01-19
NO980240D0 (no)	1998-01-19
GB9514842D0 (en)	1995-09-20
NO980240L (no)	1998-01-20
CY2408B1 (en)	2004-09-10
CA2445678C (fr)	2009-11-24
EP0839039A1 (fr)	1998-05-06
CN1117567C (zh)	2003-08-13
EG23934A (en)	2008-01-14
ES2208757T5 (es)	2007-12-16
PT839039E (pt)	2004-03-31
DK0839039T3 (da)	2004-03-08
RO119119B1 (ro)	2004-04-30
PE16098A1 (es)	1998-04-16
DK0839039T4 (da)	2007-10-08
CN1195986A (zh)	1998-10-14
CZ18398A3 (cs)	1998-06-17
HU228853B1 (en)	2013-06-28
SK5398A3 (en)	1998-07-08

Publication	Publication Date	Title
MA23942A1 (fr)	1997-04-01	Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation
MA26415A1 (fr)	2004-12-20	Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA23831A1 (fr)	1996-10-01	Derives de quinazoline, procede pour leur preparation et composition les contenant
MA26430A1 (fr)	2004-12-20	4 (3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA23866A1 (fr)	1996-12-31	N-(indole-2-carbonyl)-glycinamides substitues, procede pour leur preparation et compositions les contenant
FR2729951B1 (fr)	1997-04-18	Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
MA22521A1 (fr)	1992-12-31	Compositions anti- transpirantes en batonnets-gels contenant un derive de la 2-oxazolidinone, et procede pour leur preparation
MA26451A1 (fr)	2004-12-20	Amides inhibiteurs de secretion de apo b/mtp, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA24469A1 (fr)	1998-10-01	Derives d'acide arylsulfonyhydroxamique, procede pour leur preparation et compositions les contenant
MA26581A1 (fr)	2004-12-20	Forme hydratee nouvelle d'un derive de thiazolidine-dione, procede pour sa preparation et composition pharmaceutique la contenant
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2735777B1 (fr)	1997-09-12	Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA26519A1 (fr)	2004-12-20	Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26417A1 (fr)	2004-12-20	Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant
FR2738245B1 (fr)	1997-11-21	Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
MA26582A1 (fr)	2004-12-20	Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant
FR2569702B1 (fr)	1988-10-28	Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
MA26609A1 (fr)	2004-12-20	Derives de retiferol, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2728901B1 (fr)	1997-03-28	Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant